Immigrants with liver cancer survive longer than their U.S.-born counterparts

Foreign-born patients with hepatocellular carcinoma had higher survival rates than those born in the United States, according to data published in JNCI: Journal of the National Cancer Institute.Researchers observed the disparity in 5-year survival among foreign- vs. U.S.-born patients across the four major racial and ethnic groups.“In the end, we were pleased and delighted with this very fruitful investigation that not only confirmed the immigrants’ advantage in hepatocellular carcinoma survival, but also revealed the varied sociodemographic characteristics and survival outcomesRead More